Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dyslipidemias × Educational Status × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 39 Neoplasms 24 Lung Neoplasms 24 Colorectal Neoplasms 18 Prostatic Neoplasms 13 Hematologic Neoplasms 8 Fatigue 8 Uterine Cervical Neoplasms 7 Lymphoma 7 Anxiety Disorders 7 Neoplasm Metastasis 6 Melanoma 6 Papillomavirus Infections 5 Multiple Myeloma 5 Hematopoietic and Lymphatic System Neoplasm 5 Gastrointestinal Neoplasms 5 Skin Neoplasms 4 Obesity 4 Head and Neck Neoplasms 4 Depression 4 Carcinoma, Non-Small-Cell Lung 4 Breast Carcinoma In Situ 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Obesity-Related Malignant Neoplasm 3 Motor Activity 3 Malignant Solid Neoplasm 3 Leukemia 3 Genital Neoplasms, Female 3

Interventions

semaglutide 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Topiramate 1 Tirzepatide 1 Surveys and Questionnaires 1 Qsymia 1 Phlebotomy 1 Phentermine 1 Naltrexone 1 Metformin 1 Magnesium 1 Liraglutide 1 Glucagon-Like Peptide-1 Receptor 1 Electrocardiography 1 Educational Status 1 Diethylpropion 1 Carnitine 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03104543 2024-03-06

CHIIP

Fred Hutchinson Cancer Center

Phase NA Completed

347 enrolled 10 charts

Diabetes Mellitus, Hypertension, Neoplasms, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡